Mahmoud M S, Wang P, Chaudry I H
Center for Surgical Research and Department of Surgery, Brown University School of Medicine and Rhode Island Hospital, Providence 02903, USA.
Biochim Biophys Acta. 1997 Oct 20;1336(3):549-56. doi: 10.1016/s0304-4165(97)00069-x.
Since administration of ATP-MgCl2 following trauma and hemorrhagic shock improves tissue perfusion as well as cell and organ function, the aim of this study was to determine whether this agent has any salutary effects on the hepatic rate-controlling enzymes specific for gluconeogenesis, such as phosphoenolpyruvate carboxykinase (PEPCK), and for glycolysis, such as pyruvate kinase (PK), under such conditions. To study this, rats underwent a 5-cm midline laparotomy (i.e., trauma-induced) and were bled to and maintained at a mean arterial pressure of 40 mm Hg until 40% of maximum bleed out volume was returned in the form of Ringer's lactate (RL). The animals were then resuscitated with 3 times the volume of shed blood with RL over 45 min, followed by 2 times RL with ATP-MgCl2 (50 micromol/kg body wt.) or an equivalent volume of normal saline over 95 min. Hepatic PEPCK, PK and glucokinase activities were determined 4 h after the completion of resuscitation. The mRNA levels of PEPCK and PK in the isolated hepatocytes were determined by Northern blot analysis. The results indicate that glucokinase activity was not significantly altered after hemorrhage, irrespective of ATP-MgCl2 treatment. Although the mRNA levels of PEPCK were similar in all groups, PEPCK activity decreased significantly after hemorrhage. ATP-MgCl2 treatment, however, restored PEPCK activity. Hemorrhage resulted in an increase in PK activity and its mRNA. ATP-MgCl2 treatment significantly decreased PK activity and the mRNA. Thus, up-regulation of the gluconeogenic enzyme, PEPCK, and down-regulation of the glycolytic enzyme, PK, by ATP-MgCl2 may be responsible, in part, for the beneficial effects of this agent following trauma-hemorrhage and resuscitation.
由于创伤和失血性休克后给予三磷酸腺苷-氯化镁(ATP-MgCl2)可改善组织灌注以及细胞和器官功能,本研究的目的是确定在这种情况下,该药物对糖异生特异性的肝速率控制酶(如磷酸烯醇式丙酮酸羧激酶(PEPCK))和糖酵解特异性的酶(如丙酮酸激酶(PK))是否有任何有益作用。为了研究这一点,对大鼠进行5厘米的中线剖腹手术(即创伤诱导),并放血至平均动脉压为40毫米汞柱并维持该压力,直到以乳酸林格液(RL)的形式回输40%的最大放血量。然后在45分钟内用3倍失血量的RL对动物进行复苏,随后在95分钟内用含ATP-MgCl2(50微摩尔/千克体重)的2倍RL或等量的生理盐水进行复苏。复苏完成后4小时测定肝脏PEPCK、PK和葡萄糖激酶的活性。通过Northern印迹分析测定分离的肝细胞中PEPCK和PK的mRNA水平。结果表明,无论是否进行ATP-MgCl2处理,出血后葡萄糖激酶活性均无显著改变。尽管所有组中PEPCK的mRNA水平相似,但出血后PEPCK活性显著降低。然而,ATP-MgCl2处理可恢复PEPCK活性。出血导致PK活性及其mRNA增加。ATP-MgCl2处理显著降低了PK活性及其mRNA。因此,ATP-MgCl2对糖异生酶PEPCK的上调和糖酵解酶PK的下调可能部分解释了该药物在创伤-出血和复苏后的有益作用。